Open Access

Overexpression of C‑sis inhibits H2O2‑induced Buffalo rat liver cell apoptosis in vitro and alleviates liver injury in a rat model of fulminant hepatic failure

  • Authors:
    • Hao Ding
    • Zhili Wen
  • View Affiliations

  • Published online on: May 17, 2018     https://doi.org/10.3892/ijmm.2018.3684
  • Pages: 873-882
  • Copyright: © Ding et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate the role of the C‑sis gene in the apoptosis of hepatocytes in vitro and in the liver function of a rat model of fulminant hepatic failure (FHF). Buffalo rat liver (BRL) cells were treated with hydrogen peroxide (H2O2) to induce apoptosis and then transfected with a C‑sis overexpression vector. A rat model of FHF was established, and C‑sis was overexpressed. The mRNA and protein expression of C‑sis were examined using reverse transcription‑polymerase chain reaction and western blot analyses, respectively. Cell viability was assessed by CCK8, and a TUNEL assay was used to examine cell apoptosis. Flow cytometry was used for cell cycle detection. Hematoxylin and eosin staining was used for histological examination. The levels of alanine transaminase (ALT) and aspartate transaminase (AST) were also examined in the rats. The results showed that C‑sis was successfully overexpressed in the cells and rat model. Compared with H2O2‑treated BRL cells, the overexpression of C‑sis significantly inhibited cell apoptosis, promoted cell viability, and decreased the expression of cleaved caspase-3. Similar results were observed in the FHF rats treated with the C‑sis overexpression plasmid, compared with those treated with empty plasmids. In addition, in the FHF rats overexpressing C‑sis, histological examination showed that liver injury was alleviated, the levels of ALT and AST were significantly decreased, and mortality rate was significantly decreased, compared with those observed in the rats treated with empty plasmids. In conclusion, the overexpression of C‑sis inhibited the H2O2‑induced apoptosis of BRL cells in vitro, and alleviated liver injury, improved liver function, and decreased mortality rates in rat models of FHF.

Introduction

Fulminant hepatic failure (FHF), which is characterized by extensive hepatocyte necrosis (1), is a clinical syndrome that results from the severe impairment of liver function induced by drugs, toxins or viral hepatitis (2). Even in developed countries, the mortality rate of patients with FHF is as high as 50-90% without liver transplantation (3). However, patients with FHF usually suffer multiple organ failure, which prevents liver transplantation (4). In addition, due to donor liver shortages, high costs, complications, and the risk of organ rejection, the application of liver transplantation is limited (5). Biochemical and pathological studies have suggested that hepatocyte apoptosis is important in the development of FHF, resulting in substantial hepatocyte loss when the rate and extent of hepatocellular apoptosis are not adequately compensated by regenerative activity (5).

Under normal physiological conditions, proto-oncogenes are involved in the maintenance of tissue homeostasis (6). Proto-oncogene activation has been used to repair cardiac ischemia injury (7). The proto-oncogene C-sis encodes the B chain of platelet-derived growth factor (PDGF-B) (8). PDGF is a potent mitogen, which is released from activated hepatocytes and hepatic stellate cells (HSCs), which are involved in liver repair (9-11). At the cellular level, PDGF is one of the most well characterized fibrogenic and proliferative cytokines for HSCs. In addition, hepatic injury is associated with the upregulation of autocrine PDGF and PDGF receptor (10,12). Hao et al (13) demonstrated that the neutralization of PDGF-B suppressed the proliferation and activation of HSCs in the fibrotic mouse liver. PDGF-B may exist as a homodimer (PDGF-BB) or as a heterodimer with chain A (PDGF-AB). PDGF-BB serum levels are positively associated with survival rates among patients with FHF (14), indicating its potential role in the progression of FHF. PDGF-BB is the main stimulus for the proliferation of mesenchymal cells and is secreted by several cells residing in or passing through the liver (15). Hirota et al (16) reported that the overexpression of PDGF-BB resulted in airway hyper-responsiveness, decreased lung compliance, increased airway smooth muscle cell numbers, positive proliferating cell nuclear antigen-stained airway smooth muscle cells, and a reduction in genes encoding contractile proteins. Additionally, PDGF-BB induces the proliferation of HSCs (12,17-23) and is also essential in the progression of liver fibrosis (23,24). Therefore, it was hypothesized that C-sis may be involved in the repair of liver injury in FHF by regulating hepatocellular apoptosis.

To validate the above hypothesis in vitro and in vivo, respectively, Buffalo rat liver (BRL) cells were treated with hydrogen peroxide (H2O2) to induce apoptosis or were transfected with a C-sis overexpression vector. A rat model of FHF was established, and C-sis was overexpressed. Cell viability and apoptosis were assessed. The results showed that the overexpression of C-sis inhibited the H2O2-induced apoptosis of BRL cells in vitro, and alleviated liver injury and decreased mortality rates in the FHF rats.

Materials and methods

Plasmid construction

The full-length cDNA encoding rat C-sis (GenBank™ accession no. NM24628) was generated by reverse transcription-polymerase chain reaction (RT-PCR) from the liver tissues of Sprague-Dawley rats, using the following primers: Forward, 5′-CGCGAATTCATGAATCGCTGCTGGGC-3′ (the EcoRI site is underlined) and reverse, 5′-CCCTCTAGACTAGGCTCCAAGGATCTC-3′ (the XbaI site is underlined). The PCR products were digested and cloned into the mammalian expression vector pcDNA3.1 (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA). The plasmids were purified using the AxyPrep DNA Gel Recovery kit (Axygen Biotechnology Co., Ltd., Hangzhou, China).

Cell culture, transfection and H2O2 treatment

The BRL cells (Shanghai Cell Bank, Chinese Academy of Sciences, Shanghai, China) were cultured in DMEM containing 10% FBS (Gibco; Thermo Fisher Scientific, Inc.) in a humidified incubator at 37°C under 5% CO2. Cells in the logarithmic phase were digested with 0.25% trypsin and 0.02% EDTA, and then centrifuged at 513 × g for 5 min at 37°C. The cells (8×104 cells/well) were placed in an incubator under 5% CO2 at 37°C. Following complete attachment to the walls, 2 µg of plasmid and 4 µl of Lipo3000 (Invitrogen; Thermo Fisher Scientific, Inc.) were added. After 6-8 h, the medium was discarded and replaced with DMEM with or without the addition of 200 µM of H2O2 for 48 h. The groups used were as follows: Control (no H2O2), empty plasmid (no H2O2), C-sis plasmid (no H2O2), H2O2 group (no plasmid), empty plasmid+H2O2, and C-sis plasmid+H2O2.

Animals

Female Sprague-Dawley rats (n=100, age, 8-10 weeks, weight, 200±10 g) were purchased from Changzhou Cavens Laboratory Animal Co., Ltd. (Changzhou, China). The rats were housed one per cage in a room maintained at 24-25°C on a 12-h light/dark cycle with free access to food and water. The present study was approved by the Animal Ethics Committee of the Second Affiliated Hospital of Nanchang University (Nanchang, China). All animal procedures were performed in strict accordance with the guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996). Transfection of the target C-sis gene was performed using hydrodynamics-based transfection in vivo, as described previously (25,26).

FHF modeling and grouping

At 48 h post-transfection, 40 rats were randomized into four groups (n=10 in each group): Group A, normal control rats; group B, FHF and Ringer's solution (FHF+Ringer's solution injection group); group C, FHF and empty vector pcDNA3.1 (FHF+empty plasmid group); and group D, FHF and constructed plasmid pcDNA3.1/C-sis (FHF+C-sis plasmid group). FHF was induced through an intraperitoneal injection of 50 µg/kg of lipopolysaccharide (LPS) and 300 mg/kg of D-galactosamine (D-GalN) (27). At 8 h post-injection, the liver tissues and blood samples of the normal control group (n=10), the FHF+Ringer's solution injection group (n=9), the FHF+empty plasmid group (n=9), and the FHF+C-sis plasmid group (n=10) were collected. Another 40 rats were grouped as above (n=10 in each group) to evaluate the 24-h mortality.

C-sis mRNA

Total RNA was extracted using the Rapid Extraction kit for total RNA (Generay Biotech Co., Ltd., Shanghai, China). First-strand cDNA was synthesized from 2 µg of total RNA by using the TaqMan Reverse Transcription Reagents kit (Thermo Fisher Scientific, Inc.) with oligo(dT)16 primer. The RNA-primer mix was heated at 42°C for 5 min, and then incubated on ice for at least 1 min The PCR primers were designed using Primer Premier 5.0 software (Premier Biosoft International, Palo Alto, CA, USA) based on previously reported sequences (GenBank™ accession no. NM_24628 for C-sis, NM_81822 for β-actin). The primers were as follows: C-sis, forward, 5′-ATGACCCGAGCACATTCTGG-3′ and reverse, 5′-ACACCTCTGTACGCGTCTTG-3′; and β-actin, forward, 5′-CCCATCTATGAGGGTTACGC-3′ and reverse, 5′-TTTAATGTCACGCACGATTTC-3′. The PCR analysis was performed with 500 ng of cDNA, 1 µl of each primer, 10 µl of 2X SuperReal premix plus, and ddH2O to achieve a final volume of 20 µl. The conditions were as follows: i) 95.0°C for 15 min; ii) 40 cycles at 95.0°C for 10 sec, 60.0°C for 20 sec, and 72.0°C for 20 sec. The results were calculated and analyzed using quantitative fluorescence PCR analysis software (BIO-RAD CFX Manager version 3.0; Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Western blot analysis

Total proteins were extracted using a total protein extraction kit. The protein concentrations were determined using BCA protein assay kit (Beyotime Institute of Biotechnology, Shanghai, China). The proteins (100 µg, 7 µg/µl) were separated by 10% denaturing SDS-polyacrylamide gel electrophoresis and transferred onto a polyvinylidene difluoride membrane. The membrane was blocked with 5% non-fat dry milk for 1 h at room temperature, washed, and blotted with primary antibodies against C-sis (cat. no. ab78409; 1:400), cleaved poly (ADP-ribose) polymerase 1 (PARP1; cat. no. ab32064; 1:1,000), cleaved caspase-3 (cat. no. ab2302; 1:1,000), B-cell lymphoma 2 (Bcl-2; cat. no. ab196495; 1:1,000), Bcl-2-associated X protein (Bax; cat. no. ab32503; 1:1,000) (all from Abcam, Cambridge, MA, USA), or GAPDH (cat. no. AP0063; 1:400; Bioworld Technology, Inc., Louis Park, MN, USA), and incubated overnight at 4°C. This was followed by incubation with a horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (cat. no. A50-106P; 1:1,000; Origene Technologies, Inc, Beijing, China) at room temperature for 1 h. The bands were quantified using Quantity One 4.62 software (Bio-Rad Laboratories, Inc.). GAPDH was used as an internal control.

Histological examination

The liver tissues were fixed in 10% formaldehyde solution for 30 min at room temperature, paraffin-embedded, sectioned at 4-µm, and stained using hematoxylin and eosin at room temperature for 10 min under an Olympus BH-2 light microscope (Olympus Corporation, Tokyo, Japan).

Cell viability

Cell viability was assessed using the CCK8 assay. The cells (100 µl; 5,000 cells/well) were added to a 96-well plate. The plate was incubated for 48 h at 37°C under 5% CO2. The medium was then discarded and replaced with fresh medium containing 10 µl of CCK8 solution (Beyotime Institute of Biotechnology, Shanghai, China). Blank control wells received 0.9% saline. The plates were incubated at 37°C for 1 h in the dark. The optical density was measured at 450 nm.

TUNEL assay

Cell apoptosis was detected using a commercial TUNEL assay (cat. no. 11684817910; Roche Applied Science, Penzberg, Germany), in strict accordance with the manufacturer's protocol. The slides were counterstained using hematoxylin at room temperature for 1 min, and sealed with neutral gum.

Cell apoptosis

A Cell Apoptosis kit (UNOCI Biological Technology Co., Ltd., Hangzhou, China) was used to detect cell apoptosis, in strict accordance with the manufacturer's protocol. A flow cytometer (ACCURI C6; BD Biosciences, Franklin Lake, NJ, USA) was used to detect apoptotic cells. The data was analyzed using FlowJo software version 10.0.5 for Microsoft (FlowJo LLC, Ashland, OR, USA).

Cell cycle analysis

A Cell Cycle Analysis kit (Beyotime Institute of Biotechnology) was used to measure cell cycle data. Briefly, the cells were collected by centrifugation at 513 × g for 15 min at 37°C, washed twice with 4°C PBS, and fixed with 75% cold ethanol at 4°C for 24 h. The cells were collected by centrifugation at 513 × g for 5 min at 37°C, dried, and washed twice with PBS. Subsequently, 1 ml of Reagent A was added; the tube was then mixed well for 5-10 sec and incubated for 30 h. Flow cytometry (ACCURI C6; BD Biosciences) was used to measure cell cycle data.

Immunohistochemistry

The liver tissues were fixed with 4% paraformaldehyde solution at room temperature for 30 min, paraffin-embedded, sectioned at 4-µm, and dewaxed. Endogenous peroxidase was blocked and inactivated, and the sections were blotted overnight at 4°C with a primary antibody against caspase-3 (cat. no. ab2302; 1:100; Abcam), followed by incubation with the biotinylated rabbit secondary antibody (cat. no. BA1100; 1:375; Vector Laboratories, Inc., Burlingame, CA, USA) at 37°C for 1 h. Finally, the sections were stained with DAB and then counterstained with hematoxylin at room temperature for 1 min. Three different fields were selected from each section under an Olympus BH-2 light microscope (Olympus Corporation; magnification, ×200). The intensity of the expression and the positivity rate were measured. The expression score was calculated as the staining intensity multiplied by the percentage of positive cells, as previously described (28).

Alanine transaminase (ALT) and aspartate transaminase (AST) measurement

An ALT detection kit (Nanjing Jiancheng Bioengineering Institute, cat. no. C009-2, batch no. 20141105) and an AST detection kit (Nanjing Jiancheng Bioengineering Institute, cat. no. C0010-2, batch no. 20141104) were used in strict accordance with the manufacturer's protocol.

Statistical analysis

Data are presented as the mean ± standard deviation and were analyzed using one-way analysis of variance followed by the least significant difference test. Statistical analysis was performed using SPSS 13.0 (SPSS, Inc., Chicago, IL, USA). Each experiment was repeated three times. P<0.05 was considered to indicate a statistically significant difference.

Results

Overexpression of C-sis in BRL cells

Reactive oxygen species are crucial in FHF and acute hepatic failure (29). The present study used H2O2, which is known to induce apoptosis in mouse primary cultured hepatocytes (30), to cause oxidative stress and thereby induce apoptosis of BRL cells. Compared with the control and empty plasmid groups, the mRNA expression of C-sis in the C-sis plasmid group was significantly increased at 48 h post-transfection (P<0.01; Fig. 1A). Similarly, the protein expression of C-sis in the C-sis plasmid group at 48 h post-transfection was significantly increased when compared with the control and the empty plasmid groups (P<0.01; Fig. 1B). These results showed that C-sis was successfully overexpressed in the BRL cells.

Cell viability and cell cycle analysis in each group

Reactive oxygen species are crucial in FHF and acute hepatic failure (29). H2O2 treatment led to a significant decrease in cell viability when the concentration of H2O2 reached 150 µmol/l (Fig. 2A). As shown in Fig. 2B, the cell viability in the H2O2 group was significantly decreased compared with that in the control group (P<0.01). Compared with the empty plasmid+H2O2 group, the cell viability in the C-sis plasmid+H2O2 group was significantly increased (P<0.01). Cell cycle was assessed by flow cytometry and the results demonstrated no significant differences in cell cycle among the groups (Fig. 2C and D).

Cell apoptosis in each group

Four populations of cells were detected using flow cytometry: Q1-UL (necrotic cells and debris), Q1-UR (late stage apoptotic cells and necrotic cells), Q1-LL (normal cells), and Q1-LR (apoptotic cells at the early stage, as detected by CCK8). The sum of Q1-UR and Q1-LR was considered the apoptotic rate. Compared with the normal control group, cell apoptosis in the H2O2 group was significantly increased (P<0.01). Compared with the empty plasmid+H2O2 group, cell apoptosis of the C-sis plasmid+H2O2 group was significantly decreased (P<0.01; Fig. 3A and B). The results of the TUNEL assay were consistent with the flow cytometry results (Fig. 3C and D).

In addition, as shown in Fig. 3E, the protein expression levels of the pro-apoptotic proteins, cleaved caspase-3, cleaved PARP1 and Bax, were significantly increased in the H2O2 group, compared with those in the normal control group (P<0.01). Compared with the empty plasmid+H2O2 group, the expression levels of cleaved caspase-3, cleaved PARP1 and Bax were significantly decreased in the C-sis plasmid+H2O2 group (P<0.01). However, the anti-apoptotic protein Bcl-2 showed the opposite protein expression pattern compared with the three pro-apoptotic proteins.

Overexpression of C-sis in the FHF rat models

There was a significant increase in the mRNA expression of C-sis in the C-sis plasmid group compared with the normal control and empty plasmid groups (P<0.01; Fig. 4A), and there was a significant increase in the protein expression of C-sis in the C-sis plasmid group compared with the normal control and empty plasmid groups (P<0.01; Fig. 4B). These results showed that C-sis was successfully overexpressed in the FHF rats.

Histological examination in each group

In the normal control group, the cellular structure of the liver tissue was normal, and the liver cells were tightly arranged. The nuclei were round, and the cells were without lesions in the form of lipid droplets, inflammation or necrosis. The lobular structure was normal, and hepatocytes and sinusoidal cells were radially arranged around the central vein (Fig. 5A). In the FHF+Ringer's solution injection group, the infiltration of inflammatory cells, mainly neutrophils, was observed. Scattered cell apoptosis was observed inside the liver of eight rats, and extensive necrosis was observed in one rat. The organizational structure of the liver had disappeared, and blood stasis was observed within the sinusoid (Fig. 5A). In the FHF+empty plasmid group, the infiltration of inflammatory cells, mainly neutrophils, was observed. Scattered cell apoptosis was observed in the liver of seven rats, whereas extensive necrosis was observed in two rats. Marked blood stasis was found in the sinusoid (Fig. 5A). In the FHF+C-sis plasmid group, small focal inflammation with neutrophils was observed in the liver tissue. Cell apoptosis was observed in four rats, in which the nuclei were condensed. Cell structure was destroyed and extensive necrosis was present in one rat (Fig. 5A). Together, these results showed that the overexpression of C-sis alleviated liver injury.

Apoptosis in each group

Compared with the normal control group, there was a significant increase in cell apoptosis in the FHF+Ringer's solution injection group (P<0.01). Compared with the FHF+empty plasmid group, there was a significant decrease in cell apoptosis in the FHF+C-sis plasmid group (P<0.01; Fig. 5B and C). Compared with the normal control group, there was a significant increase in cleaved caspase-3 in the FHF+Ringer's solution injection group (P<0.01). Compared with the FHF+empty plasmid group, there was a significant decrease in cleaved caspase-3 in the FHF+C-sis plasmid group (P<0.05; Fig. 5D and E).

Serum levels of ALT and AST in each group

Compared with the normal control group, the serum levels of ALT (P<0.01) and AST (P<0.05) in the FHF+Ringer's solution injection group were significantly increased. Compared with the FHF+empty plasmid group, the serum levels of ALT (P<0.01) and AST (P<0.05) in the FHF+C-sis plasmid group were significantly decreased (Fig. 6A and B).

Animal mortality rates in each group

Within the 24-h observation period, all rats in the normal control group survived, whereas 70.0 and 80.0% of the rats died within 24 h in the FHF+Ringer's injection and FHF+empty plasmid groups, respectively. Transfection of cells with the C-sis gene effectively protected the animals from death induced by LPS/D-GalN, and only two of these rats (20.0%) died within the 24-h observation period (Table I).

Table I

Mortality rate of the rats in the animal model of FHF.

Table I

Mortality rate of the rats in the animal model of FHF.

Group0 h4 h8 h12 h24 hMortality (%)
Normal control000000.00
FHF+Ringer's solution injection0032270.00a
FHF+empty plasmid0033280.00
FHF+C-sis plasmid0002020.00b

a P<0.01 vs. normal control group;

b P<0.01 vs. FHF+empty plasmid group. FHF, fulminant hepatic failure.

Discussion

The present study aimed to investigate the role of the C-sis gene in the apoptosis of hepatocytes in vitro and in liver function in a rat model of FHF. The results showed that the overexpression of C-sis not only inhibited the H2O2-induced apoptosis of hepatocytes in vitro but also improved liver function and decreased mortality in the rat models of FHF. Previous studies have shown that FHF mainly involves hepatocyte apoptosis rather than necrosis (14,31-33). Therefore, the inhibition of hepatocyte apoptosis can assist in preventing hepatocyte necrosis.

Previous studies have shown that PDGF-BB is involved in the resistance against oxidative stress in vascular smooth muscle cells (34), neurons (35,36), the intestine (37), and liver (38). The results of the present study showed that the overexpression of C-sis inhibited H2O2-induced BRL cell apoptosis. However, no significant difference in cell cycle was observed among the groups. The possible reason for this may be that the C-sis gene can function only through cell apoptosis and exerts no effect on the cell cycle. The in vivo experiments showed that the overexpression of C-sis alleviated histological damage, improved liver function, and decreased mortality rate in the FHF rats. To a certain extent, these results are consistent with a previous study showing that low plasma levels of PDGF-BB were associated with poor prognosis in patients with FHF (14). Taken together, the results of the present study suggested that C-sis d cell viability and inhibited apoptosis, and promoted tissue repair. Therefore, it was hypothesized that C-sis may have a positive role in the repair of damaged liver tissue and in the treatment of FHF.

The basal function of C-sis is to promote the intracellular transduction of mitotic signals and promote cell proliferation (39,40). C-sis encodes PDGF-B, which is a potent mitogenic source that can stimulate the division and proliferation of mesenchymal cells, and has a positive role in promoting vascular regeneration and wound healing (41,42). PDGF-B can stimulate the healing of ulcers in diabetic rats (43). Novel technologies are being developed that focus on the slow release of PDGF-B from a membrane to accelerate wound healing in patients with diabetes (44). The loss of function caused by PDGF-B mutation can lead to primary familial cerebral calcification, resulting in neurodegenerative disease (45,46).

The present study also considered the problem of carcinogenesis that arises following the long-term presence of the proto-oncogene C-sis. The majority of current findings related to C-sis are focused on the fact that C-sis can promote cell growth and tissue repair, however, certain studies have focused on the occurrence and progression of tumors (20). This is the reason why C-sis was selected for the treatment of FHF in the present study rather than other proto-oncogenes. Second, the present study aimed to observe the efficacy of C-sis on an acute life-threatening disease, FHF. Proto-oncogenes exist in the normal human body but are usually inactive. The occurrence of cancer is a process that depends on numerous steps, and involves the activation of several proto-oncogenes and the inactivation of tumor suppressor genes; the activation of a single proto-oncogene may not cause cancer to arise. In addition, the inactivation of tumor suppressor genes is the main cause of cancer. Finally, previous studies performed experiments in which the proto-oncogene Pim-3 was used for the treatment of heart or liver failure; however, no tumor occurrence was observed (25,47).

H2O2 is a potent oxidant, and studies have shown that H2O2 can induce hepatocyte apoptosis (48,49). In the present study, LPS and D-GalN did not exert a significant effect on the proliferation of the BRL liver cell line (data not shown). Fas and ischemia-reperfusion can be separately used for the induction of mouse models of liver failure, whereas H2O2 is used to induce injury in cells (50,51). Therefore, in the present study, different methods had to be used to induce liver cell damage in the animals and in the cell line, which is a limitation of the study. Other limitations include the lack of comprehensive molecular analyses to determine the exact pathways involved in the response to the overexpression of C-sis, and the lack of investigation of the cytokines involved. In addition, only the short-term effects of the overexpression of C-sis were examined, although it is known that PDGF-BB can be involved in long-term liver fibrosis (52). These issues are to be examined in future investigations.

Increasing evidence suggests the novel involvement of the nucleolus in sensing cellular stress signals (53). Under stress conditions, the structure of the nucleolus is perturbed and certain nucleolar proteins, including ribosomal proteins, are released from the nucleolus to the nucleoplasm where they associate with Mouse Double Minute 2 (MDM2) to inhibit its activity and stabilize p53 (53,54). Reactive oxygen species are crucial in FHF (55). The present study used H2O2 to induce oxidative stress in order to induce the apoptosis of BRL cells. Upon cell exposure to H2O2, redox changes in the nucleolar compartment are associated with activation of the ribosomal protein/MDM2/p53 pathway leading to apoptosis. In addition, previous data suggests that nuclear factor (NF)-κB is involved in apoptosis as part of the cell response to the nucleolar stress triggered by 5-fluorouracil (56). Inflammation is essential for the pathogenesis of FHF (55), and the NF-κB pathway has been shown to be key in the activation of the pro-inflammatory mechanism in FHF (55,57). These findings may assist in understanding the plausible molecular mechanisms underlying the role of C-sis in apoptosis.

In conclusion, the results of the present study showed that the overexpression of C-sis inhibited the H2O2-induced apoptosis of BRL cells in vitro, and alleviated liver injury, improved liver function and decreased mortality rate in rat model of FHF. These findings may assist in understanding the progression of FHF and may provide potential therapeutic approaches.

Acknowledgments

Not applicable.

Funding

This study was funded by the National Natural Science Foundation of China (grant no. 81300348).

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

HD and ZW conceived and designed the study. HD performed the experiments and wrote the paper. ZW reviewed and edited the manuscript. All authors read and approved the manuscript.

Ethics approval and consent to participate

The present study was approved by the Animal Ethics Committee of the Second Affiliated Hospital of Nanchang University. All animal procedures were performed in strict accordance with the guidelines for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Moreau R: The pathogenesis of ACLF: The inflammatory response and immune function. Semin Liver Dis. 36:133–140. 2016. View Article : Google Scholar

2 

Tuñón M, San-Miguel B, Crespo I, Jorquera F, Santamaría E, Alvarez M, Prieto J and González-Gallego J: Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus. J Pineal Res. 50:38–45. 2011. View Article : Google Scholar

3 

Hoofnagle JH, Carithers RL Jr, Shapiro C and Ascher N: Fulminant hepatic failure: Summary of a workshop. Hepatology. 21:240–252. 1995.

4 

Campbell DA Jr, Ham JM, Mccurry KR, Lucey MR, Turcotte JG and Merion RM: Liver transplant for fulminant hepatic failure. Am Surg. 57:546–549. 1991.

5 

Andrew SdMD and Parsia AVMD: Expanding the donor pool in liver transplantation: Extended criteria donors. Clin Liver Dis. 2:156–159. 2013. View Article : Google Scholar

6 

Dunn S and Cowling VH: Myc and mRNA capping. Biochim Biophys Acta. 1849.501–505. 2015.

7 

Landau E, Tirosh R, Pinson A, Banai S, Even-Ram S, Maoz M, Katzav S and Bar-Shavit R: Protection of thrombin receptor expression under hypoxia. J Biol Chem. 275:2281–2287. 2000. View Article : Google Scholar

8 

Hellström M, Kalen M, Lindahl P, Abramsson A and Betsholtz C: Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 126:3047–3055. 1999.

9 

Zhao S, Zhang Z, Qian L, Lin Q, Zhang C, Shao J, Zhang F and Zheng S: Tetramethylpyrazine attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic angiogenesis in rats. Biomed Pharmacother. 86:521–530. 2017. View Article : Google Scholar

10 

Sun WY, Song Y, Hu SS, Wang QT, Wu HX, Chen JY and Wei W: Depletion of β-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway. J Cell Biochem. 114:1153–1162. 2013. View Article : Google Scholar

11 

Wilhelm A, Aldridge V, Haldar D, Naylor AJ, Weston CJ, Hedegaard D, Garg A, Fear J, Reynolds GM, Croft AP, et al: CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism. Gut. 65:1175–1185. 2016. View Article : Google Scholar

12 

Kastanis GJ, Hernandez-Nazara Z, Nieto N, Rincón-Sanchez AR, Popratiloff A, Dominguez-Rosales JA, Lechuga CG and Rojkind M: The role of dystroglycan in PDGF-BB-dependent migration of activated hepatic stellate cells/myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 301:G464–G474. 2011. View Article : Google Scholar

13 

Hao ZM, Fan XB, Li S, Lv YF, Su HQ, Jiang HP and Li HH: Vaccination with platelet-derived growth factor B kinoids inhibits CCl(4)-induced hepatic fibrosis in mice. J Pharmacol Exp Ther. 342:835–842. 2012. View Article : Google Scholar

14 

Takayama H, Miyake Y, Nouso K, Ikeda F, Shiraha H, Takaki A, Kobashi H and Yamamoto K: Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure. J Gastroenterol Hepatol. 26:116–121. 2011. View Article : Google Scholar

15 

van Dijk F, Olinga P, Poelstra K and Beljaars L: Targeted therapies in liver fibrosis: Combining the best parts of platelet-derived growth factor BB and interferon gamma. Front Med (Lausanne). 2:722015.

16 

Hirota JA, Ask K, Farkas L, Smith JA, Ellis R, Rodriguez-Lecompte JC, Kolb M and Inman MD: In vivo role of platelet-derived growth factor-BB in airway smooth muscle proliferation in mouse lung. Am J Respir Cell Mol Biol. 45:566–572. 2011. View Article : Google Scholar

17 

Rovida E, Navari N, Caligiuri A, Dello Sbarba P and Marra F: ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. J Hepatol. 48:107–115. 2008. View Article : Google Scholar

18 

Gressner AM and Weiskirchen R: Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 10:76–99. 2006. View Article : Google Scholar

19 

Patsenker E, Popov Y, Wiesner M, Goodman SL and Schuppan D: Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. J Hepatol. 46:878–887. 2007. View Article : Google Scholar

20 

Lin X, Kong LN, Huang C, Ma TT, Meng XM, He Y, Wang QQ and Li J: Hesperetin derivative-7 inhibits PDGF-BB-induced hepatic stellate cell activation and proliferation by targeting Wnt/β-catenin pathway. Int Immunopharmacol. 25:311–320. 2015. View Article : Google Scholar

21 

Fang L, Zhan S, Huang C, Cheng X, Lv X, Si H and Li J: TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways. Toxicol Appl Pharmacol. 272:713–725. 2013. View Article : Google Scholar

22 

Shin HW, Park SY, Lee KB, Shin E, Nam SW, Lee JY and Jang JJ: Transcriptional profiling and Wnt signaling activation in proliferation of human hepatic stellate cells induced by PDGF-BB. Korean J Hepatol. 15:486–495. 2009. View Article : Google Scholar

23 

Chen SW, Chen YX, Zhang XR, Qian H, Chen WZ and Xie WF: Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats. Gene Ther. 15:1424–1435. 2008. View Article : Google Scholar

24 

Zeng Y, Liu H, Kang K, Wang Z, Hui G, Zhang X, Zhong J, Peng W, Ramchandran R, Raj JU and Gou D: Hypoxia inducible factor-1 mediates expression of miR-322: Potential role in proliferation and migration of pulmonary arterial smooth muscle cells. Sci Rep. 5:120982015. View Article : Google Scholar

25 

Liu LM, Zhang JX, Wang XP, Guo HX, Deng H and Luo J: Pim-3 protects against hepatic failure in D-galactosamine (D-GalN)-sensitized rats. Eur J Clin Invest. 40:127–138. 2010. View Article : Google Scholar

26 

Maruyama H, Higuchi N, Nishikawa Y, Kameda S, Iino N, Kazama JJ, Takahashi N, Sugawa M, Hanawa H, Tada N, et al: High-level expression of naked DNA delivered to rat liver via tail vein injection. J Gene Med. 4:333–341. 2002. View Article : Google Scholar

27 

Sayed RH, Khalil WK, Salem HA, Kenawy SA and El-Sayeh BM: Sulforaphane increases the survival rate in rats with fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide. Nutr Res. 34:982–989. 2014. View Article : Google Scholar

28 

Kara S, Gencer B, Karaca T, Tufan HA, Arikan S, Ersan I, Karaboga I and Hanci V: Protective effect of hesperetin and naringenin against apoptosis in ischemia/reperfusion-induced retinal injury in rats. Sci World J. 2014:7978242014. View Article : Google Scholar

29 

Xiong Q, Hase K, Tezuka Y, Namba T and Kadota S: Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccha-ride-induced liver injury. Life Sci. 65:421–430. 1999. View Article : Google Scholar

30 

Kanno S, Ishikawa M, Takayanagi M, Takayanagi Y and Sasaki K: Characterization of hydrogen peroxide-induced apoptosis in mouse primary cultured hepatocytes. Biol Pharm Bull. 23:37–42. 2000. View Article : Google Scholar

31 

Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T and Nagata S: Lethal effect of the anti-Fas antibody in mice. Nature. 364:806–809. 1993. View Article : Google Scholar

32 

Tanoi T, Tamura T, Sano N, Nakayama K, Fukunaga K, Zheng YW, Akhter A, Sakurai Y, Hayashi Y, Harashima H and Ohkohchi N: Protecting liver sinusoidal endothelial cells suppresses apoptosis in acute liver damage. Hepatol Res. 46:697–706. 2016. View Article : Google Scholar

33 

Gao G, Yu Z, Yan J, Li J, Shen S, Jia B, Guan K, Gao X and Kan Q: Lowering blood ammonia prevents hepatocyte injury and apoptosis. Int J Clin Exp Med. 8:12347–12355. 2015.

34 

Salabei JK, Cummins TD, Singh M, Jones SP, Bhatnagar A and Hill BG: PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem J. 451:375–388. 2013. View Article : Google Scholar

35 

Zheng L, Ishii Y, Tokunaga A, Hamashima T, Shen J, Zhao QL, Ishizawa S, Fujimori T, Nabeshima Y, Mori H, et al: Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved. J Neurosci Res. 88:1273–1284. 2010.

36 

Zheng LS, Ishii Y, Zhao QL, Kondo T and Sasahara M: PDGF suppresses oxidative stress induced Ca2+ overload and calpain activation in neurons. Oxid Med Cell Longev. 2013:3672062013. View Article : Google Scholar

37 

Krzystek-Korpacka M, Neubauer K and Matusiewicz M: Platelet-derived growth factor-BB reflects clinical, inflammatory and angiogenic disease activity and oxidative stress in inflammatory bowel disease. Clin Biochem. 42:1602–1609. 2009. View Article : Google Scholar

38 

Urtasun R, Conde de la Rosa L and Nieto N: Oxidative and nitrosative stress and fibrogenic response. Clin Liver Dis. 12:769–790. 2008. View Article : Google Scholar

39 

Saito Y, Hojo Y, Tanimoto T, Abe J and Berk BC: Protein kinase C-alpha and protein kinase C-epsilon are required for Grb2-associated binder-1 tyrosine phosphorylation in response to platelet-derived growth factor. J Biol Chem. 277:23216–23222. 2002. View Article : Google Scholar

40 

Lindqvist A, Nilsson BO, Ekblad E and Hellstrand P: Platelet-derived growth factor receptors expressed in response to injury of differentiated vascular smooth muscle in vitro: Effects on Ca2+ and growth signals. Acta Physiol Scand. 173:175–184. 2001. View Article : Google Scholar

41 

Cheng M, Park H, Engelmayr GC, Moretti M and Freed LE: Effects of regulatory factors on engineered cardiac tissue in vitro. Tissue Eng. 13:2709–2719. 2007. View Article : Google Scholar

42 

Zhang L, Ma J, Shen T, Wang S, Ma C, Liu Y, Ran Y, Wang L, Liu L and Zhu D: Platelet-derived growth factor (PDGF) induces pulmonary vascular remodeling through 15-LO/15-HETE pathway under hypoxic condition. Cell Signal. 24:1931–1939. 2012. View Article : Google Scholar

43 

Geiger A, Walker A and Nissen E: Human fibrocyte-derived exosomes accelerate wound healing in genetically diabetic mice. Biochem Biophys Res Commun. 467:303–309. 2015. View Article : Google Scholar

44 

Chiang CH, Wu WW, Li HY, Chien Y, Sun CC, Peng CH, Lin AT, Huang CS, Lai YH, Chiou SH, et al: Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure. Cell Transplant. 24:541–559. 2015. View Article : Google Scholar

45 

Vanlandewijck M, Lebouvier T, Andaloussi Mäe M, Nahar K, Hornemann S, Kenkel D, Cunha SI, Lennartsson J, Boss A, Heldin CH, et al: Functional characterization of germline mutations in PDGFB and PDGFRB in primary familial brain calcification. PloS One. 10:e01434072015. View Article : Google Scholar

46 

Fjaer R, Brodtkorb E, Oye AM, Øye AM, Sheng Y, Vigeland MD, Kvistad KA, Backe PH and Selmer KK: Generalized epilepsy in a family with basal ganglia calcifications and mutations in SLC20A2 and CHRNB2. Eur J Med Genet. 58:624–628. 2015. View Article : Google Scholar

47 

Zhang Q, Shi S, Liu Y, Uyanne J, Shi Y, Shi S and Le AD: Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol. 183:7787–7798. 2009. View Article : Google Scholar

48 

Hwang GH, Jeon YJ, Han HJ, Park SH, Baek KM, Chang W, Kim JS, Kim LK, Lee YM and Lee S: Protective effect of butylated hydroxylanisole against hydrogen peroxide-induced apoptosis in primary cultured mouse hepatocytes. J Vet Sci. 16:17–23. 2015. View Article : Google Scholar

49 

Ma X, Han S, Zhang W, Fan YJ, Liu MN, Liu AY and Liu BR: Protection of cultured human hepatocytes from hydrogen peroxideinduced apoptosis by relaxin-3. Mol Med Rep. 11:1228–1234. 2015. View Article : Google Scholar

50 

Moniaux N, Song H, Darnaud M, Garbin K, Gigou M, Mitchell C, Samuel D, Jamot L, Amouyal P, Amouyal G, et al: Human hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured livers. Hepatology. 53:618–627. 2011. View Article : Google Scholar

51 

Ramsey HE, Da Silva CG, Longo CR, Csizmadia E, Studer P, Patel VI, Damrauer SM, Siracuse JJ, Daniel S and Ferran C: A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression. Liver Transpl. 15:1613–1621. 2009. View Article : Google Scholar

52 

Lou SM, Li YM, Wang KM, Cai WM and Weng HL: Expression of platelet-derived growth factor-BB in liver tissues of patients with chronic hepatitis B. World J Gastroenterol. 10:385–388. 2004. View Article : Google Scholar

53 

Boulon S, Westman BJ, Hutten S, Boisvert FM and Lamond AI: The nucleolus under stress. Mol Cell. 40:216–227. 2010. View Article : Google Scholar

54 

Russo A, Saide A, Smaldone S, Faraonio R and Russo G: Role of uL3 in multidrug resistance in 53-mutated lung cancer cells. Int J Mol Sci. 18:E5472017. View Article : Google Scholar

55 

Lv H, Qi Z, Wang S, Feng H, Deng X and Ci X: Asiatic acid exhibits anti-inflammatory and antioxidant activities against lipopolysaccharide and d-Galactosamine-induced fulminant hepatic failure. Front Immunol. 8:7852017. View Article : Google Scholar

56 

Russo A, Saide A, Cagliani R, Cantile M, Botti G and Russo G: rpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFκB upon 5-FU treatment. Sci Rep. 6:383692016. View Article : Google Scholar

57 

Lawrence T: The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 1:a0016512009. View Article : Google Scholar

Related Articles

Journal Cover

August-2018
Volume 42 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ding H and Wen Z: Overexpression of C‑sis inhibits H2O2‑induced Buffalo rat liver cell apoptosis in vitro and alleviates liver injury in a rat model of fulminant hepatic failure. Int J Mol Med 42: 873-882, 2018.
APA
Ding, H., & Wen, Z. (2018). Overexpression of C‑sis inhibits H2O2‑induced Buffalo rat liver cell apoptosis in vitro and alleviates liver injury in a rat model of fulminant hepatic failure. International Journal of Molecular Medicine, 42, 873-882. https://doi.org/10.3892/ijmm.2018.3684
MLA
Ding, H., Wen, Z."Overexpression of C‑sis inhibits H2O2‑induced Buffalo rat liver cell apoptosis in vitro and alleviates liver injury in a rat model of fulminant hepatic failure". International Journal of Molecular Medicine 42.2 (2018): 873-882.
Chicago
Ding, H., Wen, Z."Overexpression of C‑sis inhibits H2O2‑induced Buffalo rat liver cell apoptosis in vitro and alleviates liver injury in a rat model of fulminant hepatic failure". International Journal of Molecular Medicine 42, no. 2 (2018): 873-882. https://doi.org/10.3892/ijmm.2018.3684